European Medicines Agency

EU drug agency recommends approving anti-inflammatory medicine to treat severe COVID cases

The Amsterdam-based EMA said it can now be used on adult COVID-19 patients who are being treated with corticosteroids and require supplemental oxygen or mechanical ventilation.

published on : 7th December 2021

EU authorises 2 medicines for people at risk of severe COVID

The EMA described the safety profile of both medicines as “favourable," and said that despite a small number of side effects, “the medicines' benefits are greater than their risks.”

published on : 11th November 2021